How we treat mature B-cell neoplasms (indolent B-cell lymphomas).
Ontology highlight
ABSTRACT: Mature B cell neoplasms, previously indolent non-Hodgkin lymphomas (iNHLs), are a heterogeneous group of malignancies sharing similar disease courses and treatment paradigms. Most patients with iNHL have an excellent prognosis, and in many, treatment can be deferred for years. However, some patients will have an accelerated course and may experience transformation into aggressive lymphomas. In this review, we focus on management concepts shared across iNHLs, as well as histology-specific strategies. We address open questions in the field, including the influence of genomics and molecular pathway alterations on treatment decisions. In addition, we review the management of uncommon clinical entities including nodular lymphocyte-predominant Hodgkin lymphoma, hairy cell leukemia, splenic lymph
SUBMITTER: Lumish M
PROVIDER: S-EPMC7789477 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA